Dr. Avery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
525 E Micheltorena Street
Ste A
Santa Barbara, CA 93103Phone+1 805-963-1648- Is this information wrong?
Summary
- Robert L. Avery, MD is the founder and CEO of California Retina Consultants, Santa Barbara CA. He received his medical degree from Johns Hopkins University and took his ophthalmology training there at the Wilmer Eye Institute. He completed a vitreoretinal fellowship at Duke University under Dr. Robert Machemer, Brooks McCuen, and Gene de Juan. Dr. Avery returned to Johns Hopkins as Assistant Chief of Service and head of the trauma unit. He later went on to found California Retina Consultants, which grew into one of the largest retina practices in California and recently merged with several other national practices to form Retina Consultants of America.During the growth and expansion of CRC, Dr. Avery continued clinical and basic science research, especially in the field of angiogenesis and VEGF. He and his colleges at CRC had a role in pioneering the clinical use of anti-VEGF agents for retinal diseases. He founded the California Retina Research Foundation, which currently has over 30 active clinical research trials ongoing.
D. Avery has received numerous honors and awards, including Senior honor awards from the American Academy of Ophthalmology and the American Society of Retina Specialists, where he also serves on the board of directors. He was the first recipient of the Ronald G. Michels Fellowship Award. He is a member of the American Academy of Ophthalmology, the Retina Society, the Macula Society, the American Society of Retinal Specialists, the Vit-Buckle Society, and the Association for Research in Vision and Ophthalmology. He is a member of the Medical Leadership Board of Retina Consultants of America.
Dr. Avery is the co-editor of Retina Today, and he has published over 90 peer-reviewed articles on retinal diseases. His interests include the development of improved retinal drugs and their delivery, and he holds patents in retinal drug delivery. He is a partner in two ophthalmology venture capital companies, and he is on the board of several start-up
Education & Training
Johns Hopkins UniversityResidency, Ophthalmology, 1988 - 1993
Santa Barbara Cottage HospitalInternship, Internal Medicine, 1987 - 1988- Johns Hopkins University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1993 - 2025
NC State Medical License 1991 - 2003
MD State Medical License 1992 - 1994- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Fellow (FAAO) American Academy of Ophthalmology
- Join now to see all
Clinical Trials
- Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema Start of enrollment: 2005 Jun 01
- Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab Start of enrollment: 2011 Jul 01
- Analysis of Aqueous and Vitreous Humor Start of enrollment: 2015 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Suprachoroidal Space Injection Technique: Expert Panel Guidance.Cunningham, E., Ciulla, T., Wykoff, C., Avery, R., Barakat, M., Boyer, D., Brown, D., Brucker, A., Heier, J., Holekamp, N., Kaiser, P., Khanani, A., Kim, J., Demirci, ...> ;Retina. 2024 Mar 5
- Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.Humayun, M., Clegg, D., Dayan, M., Kashani, A., Rahhal, F., Avery, R., Salehi-Had, H., Chen, S., Chan, C., Palejwala, N., Ingram, A., Mitra, D., Pennington, B., Hinman...> ;Ophthalmology. 2023 Dec 30
- 1 citationsAflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME.Robert L Avery, Karl G Csaky, Peter Westenskow, Ivaylo Stoilov, Cheikh Diack> ;Translational Vision Science & Technology. 2023 Oct 3
- Join now to see all
Press Mentions
![Market Cap of EyePoint Pharmaceuticals Inc. [EYPT] Reaches 65.23M – Now What?](https://doximity-res.cloudinary.com/image/upload/v1548182789/kavzrgv8jox02dosax1a.png)
Market Cap of EyePoint Pharmaceuticals Inc. [EYPT] Reaches 65.23M – Now What?November 27th, 2020- EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4November 19th, 2020
- REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of in-Office Delivery Platform for RGX-314September 4th, 2019
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Spanish
Hospital Affiliations
Community Memorial HospitalVentura, California- Goleta Valley Cottage HospitalSanta Barbara, California
Marian Regional Medical CenterSanta Maria, California
Providence Saint John's Health CenterSanta Monica, California
Santa Barbara Cottage HospitalSanta Barbara, California
St. John's Pleasant Valley HospitalCamarillo, California
St. John's Regional Medical CenterOxnard, California
St. Mary Medical Center Long BeachLong Beach, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
